Latest Headlines
-
Photo gallery: Heersink staff honored at inaugural Dean’s Excellence Awards for Staff reception
Nine Heersink staff members were honored at the 2023 Dean’s Excellence Awards for Staff reception. Recipients, guests, and Heersink leaders gathered in the Wallace Tumor Institute Lobby on Sept. 14 to celebrate the inaugural group of honorees. Read about this year's honorees and see photos from the reception. -
Hopson named 2023 Dean’s Excellence Award for Staff winner
Betsy Hopson, MSHA, director of the UAB Staging Transition for Every Patient (STEP) Program in the Division of General Internal Medicine, has been selected as a recipient of the inaugural Heersink Dean’s Excellence Award for Staff. -
Agne named 2023 Dean’s Excellence Awards for Staff winner
April Agne, MPH, program director II in the UAB Division of Preventive Medicine and deputy director of the Forge AHEAD Center, has been selected as a recipient of the inaugural Heersink Dean’s Excellence Award for Staff. -
Marnix E. Heersink Institute for Biomedical Innovation hosts Generative AI for Healthcare Symposium
The Marnix E. Heersink Institute for Biomedical Innovation held a symposium titled "Generative AI for Healthcare: Progress or Peril" with multiple speakers, all innovators in the field of health care, on Tuesday, Sept. 12. -
Meet the UAB doctors protecting Alabama from killer fungi
Alabama is a hotbed for fungal diseases — which is why experts in treating and tracking problematic fungi gravitate to UAB. This is great news for Alabamians as killer fungi become a worldwide threat. -
Flu: Interferon-gamma from T follicular helper cells is required to create lung-resident memory B cells
Lung-resident memory B cells produced during influenza are long-living immune cells that migrate to the lungs from draining lymph nodes and lie in wait as early responders that can quickly react to future infections. They are key sentinels against subsequent viral variants. -
Announcing the third class of Momentum Leaders in Medicine at UAB
Momentum in Medicine's third cohort includes an impressive list of 15 women leaders from a variety of roles, departments, and backgrounds within UAB Medicine. -
UAB trauma surgeon makes the case for how teletrauma can help rural trauma patients
UAB researchers make a case for utilizing telehealth technologies in the care of injured rural patients stating that teletrauma can improve access to trauma care for rural patients. -
Nine Heersink staff selected for inaugural Dean’s Excellence Awards for Staff
Heersink School of Medicine is proud to announce nine staff members have been selected as the inaugural Dean’s Excellence Awards for Staff winners. -
NHLBI awards $36.7 million to UAB for continuation of CARDIA Study
Since 1985, the Coronary Artery Risk Development in Young Adults study has examined the factors that contribute to the development of cardiovascular disease to better understand the natural history of cardiovascular disease over the adult life course. -
In Type 1 diabetes, verapamil prevents decline of IGF-1 and promotes beta-cell IGF-1 signaling
These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1. -
UAB Medicine Institute for Leadership Alumni Reception
On Thursday, Aug. 10, the UAB Medicine Leadership Development Office (LDO) held its first annual reception to honor the participants of six cohorts (91 graduates) who have completed the UAB Medicine Institute for Leadership. -
Osteoporosis: UAB-led study approved for a $13.9 million award to investigate prevention of bone fractures
The study, funded by the Patient-Centered Outcomes Research Institute, will compare two pathways of post-fracture patient care. -
A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans
Frances Lund, Ph.D., Charles H. McCauley professor in the Department of Microbiology and director of the Immunology Institute, and Anoma Nellore, M.D., associate professor in the Division of Infectious Diseases, are the latest winners of the Heersink School of Medicine's Featured Discovery. This initiative celebrates important research from Heersink faculty members.
-
Informatics award highlights research in cancer algorithms
John Osborne, Ph.D., assistant professor of Medicine at the Informatics Institute, recently received a notice of award for a U24 supplement to develop a cancer algorithm predicting the severity of cancer recurrence in patients. The work will build on previously funded work to identify recurrence retrospectively in UAB cancer patients using structured EHR data and clinical text. -
A fate determination fork-in-the-road for germinal center Tfh and T memory cells
Some PD-1+CXCR5+CD4+ T cells will become germinal center-Tfh cells that are essential for B cells to become high-affinity antibody-producing cells. Others do not take that path, instead becoming memory T cells. -
Introduction to Applications of Artificial Intelligence in Medicine with Dr. Ryan Godwin and Dr. Sandeep Bodduluri
Ryan Godwin, Ph.D., instructor in the Department of Anesthesiology and Perioperative Medicine and the Department of Radiology, and Sandeep Bodduluri, Ph.D., assistant professor in the Department of Medicine and Instructor & Advisor for AI Programming for the Marnix E. Heersink Institute for Biomedical Innovation, have partnered to instruct the institute’s new graduate certificate course, Applications of Artificial Intelligence in Medicine. -
$6.9 million awarded to UAB to continue knee osteoarthritis research
$46 million awarded by NIH to UAB and partners allows researchers to continue following participants enrolled in the national Multicenter Osteoarthritis Study. -
New kidney function equation may reduce health disparities by improving access to heart failure therapy in previously ineligible patients
The newly introduced kidney function equation has value in predicting heart failure comparable to the old equation but may reduce racial disparities by improving access to heart failure therapy among Black heart failure patients. -
NIH selects Marrazzo as director of the National Institute of Allergy and Infectious Diseases
Today the National Institutes of Health has announced that UAB’s own Jeanne Marrazzo, M.D., has been selected to succeed Anthony Fauci, M.D., as the next director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) this fall.
